查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964091

生物样本采集试剂盒市场－全球产业规模、份额、趋势、机会和预测：按产品、应用、最终用途、地区和竞争对手划分，2021-2031年

Biological Sample Collection Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product, By Application, By End-Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球生物检体采集试剂盒市场预计将从 2025 年的 84.9 亿美元成长到 2031 年的 128.6 亿美元，复合年增长率为 7.17%。

这些试剂盒包含一套完整的仪器和保存试剂，旨在采集、稳定和运输血液、唾液和组织等检体，用于诊断和研究。推动市场成长的主要因素是全球慢性病和感染疾病需要广泛的临床检测和持续监测。此外，生物银行基础设施的快速发展以及远端患者监护的日益普及，也推动了对高效便捷、支援分散式检查模式的采集解决方案的需求。

市场概览
预测期 2027-2031
市场规模：2025年 84.9亿美元
市场规模：2031年 128.6亿美元
复合年增长率：2026-2031年 7.17%
成长最快的细分市场 棉花棒
最大的市场 北美洲

为了佐证检体处理的巨大需求，欧洲医疗技术协会（MedTech Europe）预测，到2024年，欧洲医疗技术市场规模将达到约1,700亿欧元，其中体外诊断将成为最大的细分市场。儘管需求强劲，但维持低温运输物流的高成本和复杂性已成为市场扩张的重大障碍。运输过程中的温度波动会对检体完整性和诊断准确性构成严重威胁，因此，严格的温度控製成为限制市场成长的因素。

市场驱动因素

全球感染疾病和慢性病发病率的上升趋势是生物检体采集试剂盒市场的主要驱动力，这使得频繁的诊断筛检和持续的疾病管理变得尤为重要。随着长期健康问题的日益普遍，医疗保健系统越来越依赖有效的检体收集工具来进行患者照护和早期检测。例如，美国疾病管制与预防中心（CDC）在2025年4月报告称，到2023年，76.4%的美国成年人将至少患有一种慢性病，这证实了需要定期体检的人群数量庞大。这项负担促使人们加大对相关研究的资金投入，截至2025年10月，美国国家癌症研究所2025财年的预算维持在72.2亿美元，这保证了临床试验和预防性筛检所需耗材的持续需求。

同时，居家检测和消费者导向的直接检测的快速成长正在重塑整个产业格局，使诊断流程去中心化。患者越来越多地选择微创的自采血方法，这些方法既私密又便捷，从而减少了对传统采血中心的需求。专注于远距物流的数位医疗服务提供者的成功凸显了这一转变。 《商业与金融》杂誌2025年3月报道称，LetsGetChecked在2024年的销售额达到了5亿美元，反映出消费者接受度的激增。这一趋势促使製造商开发出用户友好型试剂盒，以确保检体在标准邮寄运输过程中保持稳定，从而推动市场向传统临床环境之外拓展。

市场挑战

维持低温运输物流的高昂成本和复杂性是生物检体采集试剂盒市场成长的主要障碍。确保检体完整性需要从采集到检查室的无缝、温控供应链，这需要昂贵的专用包装、冷藏运输和持续监控。这些经济投入推高了诊断检测的整体成本，限制了成本敏感市场和基础设施不足地区的试剂盒普及。因此，对这种资源密集型物流的依赖阻碍了分散式检查的扩充性，使得医疗机构难以证明为防止检体劣化所需的高昂营运成本的合理性。

该市场对物流的严格要求体现在国际运输枢纽的严格标准。 2024年，国际航空运输协会（IATA）指出，全球已有超过500个站点通过了其专门的医药物流检验计画。如此庞大的认证网络凸显了该行业面临的营运挑战，因为检体必须经过这些监管严格的枢纽才能确保其有效性。任何此类专业基础设施的缺陷或偏差都可能导致温度偏差，进而造成检体失效和经济损失。这些都将直接阻碍市场渗透。

市场趋势

向永续和可生物降解材料的转变正在从根本上改变市场上的製造和物流策略。在日益严格的环境法规和企业净零排放目标的推动下，製造商正在加速用生物基聚合物取代一次性塑料，并透过采用常温运输解决方案来减少对低温运输的依赖。这一转变得到了「实验室永续发展运动」的支持，该运动倡导环保采购，以应对诊断测试对环境的影响。根据英国英国化学学会 (RSC) 2024 年 9 月发布的一份报告，全球实验室每年产生约 550 万吨塑胶废弃物，这一数字正在加速整个行业对可回收和废弃物的检体运输设计的呼吁。

同时，液态生物检体和非侵入性采样技术的快速普及推动了对专门用于保存细胞游离DNA (cfDNA) 的血液采集装置的需求。与标准静脉穿刺装置不同，这些先进的试剂盒使用专有的防腐剂在室温下稳定循环肿瘤DNA，防止基因组降解。这为肿瘤学领域提供了一种替代侵入性组织切片检查的方法。血液基因组检测数量的成长也印证了这个趋势。 2024年11月，Natera公司报告称，仅在第三季度就进行了约137,100例肿瘤检测，与去年同期相比增长了54.4%，这表明非侵入性检测工具在临床实践中得到了大规模应用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：生物样本采集试剂盒的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 分装产品（拭子、病毒保存培养基、血液采集试剂盒）
    • 透过应用（诊断、调查）
    • 依最终用途（医院/诊所、诊断中心、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美生物样本采集试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲生物样本采集试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区生物样本采集试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲生物样本采集试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美生物样本采集试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球生物样本采集试剂盒市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Seegene Inc.
  • Medline Industries, Inc.
  • Altona Diagnostics GmbH
  • CTK Biotech, Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23895

The Global Biological Sample Collection Kits Market is projected to expand from USD 8.49 Billion in 2025 to USD 12.86 Billion by 2031, registering a CAGR of 7.17%. These kits consist of comprehensive assemblies of instruments and preservation reagents designed to collect, stabilize, and transport specimens like blood, saliva, and tissue for diagnostic and research purposes. Market growth is primarily fueled by the increasing global prevalence of chronic and infectious diseases, which require extensive clinical testing and continuous surveillance. Furthermore, the rapid development of biobanking infrastructure and a rising preference for remote patient monitoring have bolstered demand for efficient, user-friendly collection solutions that support decentralized testing models.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.49 Billion
Market Size 2031USD 12.86 Billion
CAGR 2026-20317.17%
Fastest Growing SegmentSwabs
Largest MarketNorth America

Highlighting the scale of specimen processing needs, MedTech Europe estimated the European medical technology market at approximately €170 billion in 2024, with in vitro diagnostics standing out as the largest sector. Despite this strong demand, market expansion faces a significant hurdle due to the high costs and complexities associated with maintaining cold chain logistics. Temperature fluctuations during transit pose a serious risk to sample integrity and diagnostic accuracy, making the requirement for strict temperature control a limiting factor for broader market reach.

Market Driver

The increasing global prevalence of infectious diseases and chronic conditions acts as a major driver for the biological sample collection kits market, necessitating frequent diagnostic screening and ongoing disease management. As long-term health issues become more common, healthcare systems depend on effective specimen collection tools for patient care and early detection. For example, the Centers for Disease Control and Prevention reported in April 2025 that 76.4% of US adults had at least one chronic condition in 2023, underscoring the vast population needing regular diagnostics. This burden has led to strong financial backing for research; the National Cancer Institute's budget for fiscal year 2025 was maintained at $7.22 billion as of October 2025, ensuring continued demand for supplies used in clinical trials and preventive screening.

Concurrently, the industry is being reshaped by the rapid growth of home-based and direct-to-consumer testing, which decentralizes the diagnostic process. Patients are increasingly choosing minimally invasive, self-administered collection methods that provide privacy and convenience, reducing the need for traditional phlebotomy centers. This shift is highlighted by the success of digital health providers specializing in remote logistics; Business & Finance reported in March 2025 that LetsGetChecked achieved a turnover of $500 million in 2024, reflecting surging consumer adoption. This trend pushes manufacturers to develop user-friendly kits that maintain sample stability during standard mail transport, extending market reach beyond traditional clinical settings.

Market Challenge

The significant expense and complexity involved in maintaining cold chain logistics represent a major obstacle to the growth of the biological sample collection kits market. Ensuring sample integrity demands an unbroken, temperature-controlled supply chain from collection to the laboratory, requiring costly specialized packaging, refrigerated transport, and continuous monitoring. This financial requirement raises the overall cost of diagnostic testing, limiting the accessibility of these kits in cost-sensitive markets or regions with inadequate infrastructure. Consequently, reliance on such resource-intensive logistics hinders the scalability of decentralized testing, as healthcare providers find it difficult to justify the high operational costs needed to prevent specimen degradation.

The logistical rigidity necessary for this market is underscored by the strict standards applied to global transport hubs. In 2024, the International Air Transport Association noted that over 500 stations globally were certified under its specialized pharmaceutical logistics validation program. This need for a vast, certified network highlights the operational challenges facing the industry, as samples must traverse these highly regulated nodes to ensure viability. Any gap or deviation in this specialized infrastructure risks temperature excursions, resulting in sample invalidation and financial losses that directly impede broader market adoption.

Market Trends

The move toward sustainable and biodegradable materials is fundamentally transforming manufacturing and logistics strategies within the market. Driven by tighter environmental regulations and corporate net-zero targets, manufacturers are increasingly replacing single-use plastics with bio-based polymers and adopting ambient shipping solutions to reduce reliance on cold chains. This shift is supported by the laboratory sustainability movement, which encourages eco-friendly procurement to address the environmental impact of diagnostics. According to the Royal Society of Chemistry in September 2024, global laboratories generate an estimated 5.5 million metric tons of plastic waste annually, a figure that is spurring an industry-wide push for recyclable and waste-reducing specimen transport designs.

At the same time, the rapid uptake of liquid biopsy and non-invasive sampling methods is driving demand for specialized blood collection devices tailored to preserve cell-free DNA (cfDNA). Unlike standard venipuncture tools, these advanced kits utilize proprietary preservatives to stabilize circulating tumor DNA at room temperature, preventing genomic degradation and offering an alternative to invasive tissue biopsies in oncology. This trend is demonstrated by the rising volume of blood-based genomic tests; Natera, Inc. reported in November 2024 that it performed approximately 137,100 oncology tests in the third quarter alone, marking a 54.4% year-over-year increase and indicating massive clinical adoption of these non-invasive tools.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Seegene Inc.
  • Medline Industries, Inc.
  • Altona Diagnostics GmbH
  • CTK Biotech, Inc

Report Scope

In this report, the Global Biological Sample Collection Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Sample Collection Kits Market, By Product

  • Swabs
  • Viral Transport Media
  • Blood Collection Kits

Biological Sample Collection Kits Market, By Application

  • Diagnostics
  • Research

Biological Sample Collection Kits Market, By End-Use

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

Biological Sample Collection Kits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biological Sample Collection Kits Market.

Available Customizations:

Global Biological Sample Collection Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Sample Collection Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Swabs, Viral Transport Media, Blood Collection Kits)
    • 5.2.2. By Application (Diagnostics, Research)
    • 5.2.3. By End-Use (Hospitals and Clinics, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Biological Sample Collection Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Sample Collection Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Biological Sample Collection Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Biological Sample Collection Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Biological Sample Collection Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biological Sample Collection Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. France Biological Sample Collection Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. United Kingdom Biological Sample Collection Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. Italy Biological Sample Collection Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Biological Sample Collection Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia Pacific Biological Sample Collection Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biological Sample Collection Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Biological Sample Collection Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Biological Sample Collection Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Biological Sample Collection Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Biological Sample Collection Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. Middle East & Africa Biological Sample Collection Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biological Sample Collection Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. UAE Biological Sample Collection Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. South Africa Biological Sample Collection Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. South America Biological Sample Collection Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biological Sample Collection Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Colombia Biological Sample Collection Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. Argentina Biological Sample Collection Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biological Sample Collection Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. QIAGEN NV
  • 15.3. F. Hoffmann-La Roche Ltd
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Becton, Dickinson and Company
  • 15.6. Laboratory Corporation of America Holdings
  • 15.7. Seegene Inc.
  • 15.8. Medline Industries, Inc.
  • 15.9. Altona Diagnostics GmbH
  • 15.10. CTK Biotech, Inc

16. Strategic Recommendations

17. About Us & Disclaimer